Clinical Trials Directory

A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy

Connecting People With Cancer to Employment Support

Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors

Monitoring Patient Prostate Health Post Therapy

Vaginal Dilator Therapy After Pelvic Radiation

Molecular Breast Imaging (MBI)-Guided Biopsy

Artificial Intelligence - Assisted Model for Optimal Timing of Surgery in Advanced Ovarian Cancer

A Study to Learn More About Tukysa Once it is Out in the Korean Market

Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer

Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors

Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function

Mediterranean Diet Intervention Among Men at LBJ Hospital With Prostate Cancer

Vapor Ablation for Localized Cancer Lesions

Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression

RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

Life Expectancy-informed Colorectal Cancer Screening

Colorectal Cancer Screening in the Homeless

Effectiveness of an EHealth Intervention for Uptake of Cervical Cancer Screening in Hispanic Women

Erector Spinae Block vs. Placebo Block Study

BAriaTric Surgery After Breast Cancer Treatment (BATS)

Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)

Study of a 1-Millimeter Resolution Clinical Positron Emission Tomography (PET) System in Head and Neck Cancer Imaging

Modulatory Effect of Prodigiosin or Pioglitazone on TIME and the Crosstalk to Immune-Checkpoint Protein(s)

Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients

Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

1. SAFE-AI ONCO-TRACK: Multimodal GenAI for Early Detection of Minimal Residual Disease and Recurrence in Gastrointestinal Oncology

Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Early Intervention

ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity (INTERPRET)

PET/MRI in Rectal Cancer

A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2

Combined Program of Supervised Physical Exercise and Nutritional Counseling in Ovarian Cancer Patients on Frontline Maintenance Treatment With PARP Inhibitors

Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery

Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)

This Protocol Focuses on the Factors That Influence Survival, the Development of Complications and the Quality of Life Based on the Treatment Received in the Group of Patients Suffering From Malignant Lesions of the Head and Neck

SERS Sensor Based on CHA Reaction for EGFR Mutation Typing in Advanced Lung Cancer

Platform Trial Assessing Uptake, Safety and Efficacy of Theranostic Agents in Solid Tumors With Active Brain Metastases

Geriatric Assessment and Technology Evaluation in Prostate Cancer

Food is Medicine in Survivorship: Examining the Feasibility and Impact of a Scalable Food Delivery and Culinary Medicine Program (FoodiiS) Among Pediatric Cancer Survivors and Their Families

Improving Outcomes in Early Menopause After Cancer

SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis

SERS-Based Serum Molecular Spectral Screening for Benign and Malignant Pulmonary Proliferative Nodules

Pilot Study of an Aerobic Exercise Intervention During Immune Checkpoint Inhibitor Therapy in Early-stage Triple Negative Breast Cancer

SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type

SERS-Based Serum Molecular Spectral Detection of Invasive Lung Cancer

Strategies to Decentralize Breast Ultrasound in Rwanda

Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance Imaging

Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers